• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SEIKAGAKU CORPORATION ARTZ DISPO; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SEIKAGAKU CORPORATION ARTZ DISPO; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Lot Number 5L3C08
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Bacterial Infection (1735)
Event Date 07/12/2023
Event Type  Injury  
Manufacturer Narrative
We are investigating the production records.This case was reported from a physician.The lot number of artz dispo was 5l3c08.The patient was transported urgently and we couldn't investigate because information on transported hospital was not obtained.According to the reporting physician, the injection technique was no problem, because there were no problems for the first and second injections.The physician disinfected the knee with isodine and wore gloves.The physician instructed him to rest and take no bathing.It was considered that infection accidentally happened, and septic arthritis was highly probably related to artz dispo.Company comment: all of product batches passed with the release test including the sterility test before the product release.It is therefore highly unlikely that the product quality was related to the infection.The manufacturer's causality assessment is determined as "not related".
 
Event Description
(b)(6) 2023 - a 91-year-old male patient received an injection of artz dispo for right gonarthrosis.(b)(6) 2023 - he received an injection of artz dispo.(b)(6) 2023 - he received an injection of artz dispo.(b)(6) 2023 - he had pain and swelling on the right knee from the night.(b)(6) 2023 - he visited the clinic.He had septic arthritis.A physician confirmed knee effusion and prescribed levofloxacin half tablet/day and acetaminophen 300 mg two tablets/day.He had a blood test.(b)(6) 2023 - he finished taking levofloxacin half tablet/day and acetaminophen 300 mg two tablets/day.(b)(6) 2023 - he was transported urgently.(b)(6) 2023 - the outcome was not resolved.
 
Manufacturer Narrative
This is a definitive report.We corrected h.6 adverse event problem of fda investigation findings from 3221 to 213, and fda investigation conclusions from 11 to 67.We had the result of investigations for no.5l3c08 and changed company comment below.According to the reporting physician, the injection technique was no problem, because there were no problems for the first and second injections.The physician disinfected the knee with isodine and wore gloves.The physician instructed him to rest and take no bathing.It was considered that infection accidentally happened, and septic arthritis was highly probably related to artz dispo.Company comment: according to the result of investigations, there were no deviations or out-of-specifications found in the manufacturing process, the in-process testing, the release testing, and the environmental monitoring for lot no.5l3c08.Manufacturer's causality assessment is determined as "not related".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARTZ DISPO
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
SEIKAGAKU CORPORATION
marunouchi center building
6-1, marunouchi 1-chome
chiyoda-ku, tokyo 100-0 005
JA  100-0005
Manufacturer (Section G)
SEIKAGAKU CORPORATION - TAKAHAGI PLANT
258-5, aza-matsukubo
oaza-akahama
takahagi-shi, ibaraki 318-0 001
JA   318-0001
Manufacturer Contact
pharmacovigilance dept.
marunouchi center building
6-1, marunouchi 1-chome
chiyoda-ku, tokyo 100-0-005
JA   100-0005
MDR Report Key17623117
MDR Text Key321939659
Report Number9612392-2023-00004
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P980044
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/28/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/25/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Lot Number5L3C08
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/28/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/08/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Hospitalization;
Patient Age91 YR
Patient SexMale
-
-